GPI and experimental autoimmune encephalomyelitis: Subsequently, the in vivo efficacy of PEG21-2idT was investigated in two mouse models of autoimmunity, experimental autoimmune encephalomyelitis (EAE; Lubberts et al. 2001) and glucose-6-phosphate isomerase (GPI)-induced RA (Koenders et al. 2005).